More than a million people have received a vaccination against respiratory syncytial virus (RSV) following its rollout this ...
The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...
Vaccination rates for Covid and the flu are low for adults in the U.S. so far this season, according to a new CDC report.
Doctors say RSV trends are returning to pre-pandemic levels. Some hospitals in the U.S. are seeing an increase in RSV and higher levels of "walking pneumonia" among young children despite overall ...
According to a new report from the Centers for Disease Control and Prevention, the rates of flu, COVID-19 and respiratory ...
The government is spending $174.5 million on a ”world-leading” program, which will see pregnant people and newborn babies ...
Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...